40.6K
Downloads
118
Episodes
Equity.Guru's Chris Parry and his expert journalism team talk to business leaders, executives and investors about opportunities in North America and beyond.
Episodes
Tuesday Aug 06, 2019
Tuesday Aug 06, 2019
Eureka 93 (ERKA.C) is trying to get back on track in the wake of a dissolved partnership with Canopy Growth (WEED.T), a 15:1 share rollback and an eight-month trading halt.
Shares lost 90% of their value when folks who had been forced to sit on the stock during the halt dumped their shares on the open market.
Equity.Guru's own Chris Parry had written about the company and its troubles since the days of Livewell and at Eureka's request, sat down with company CEO, David Rendimonti, to get a closer look at Eureka 93 as well as an explanation for the company's activities during the halt. Prickly questions were asked and answered.
Listen in!
Thursday Aug 01, 2019
Thursday Aug 01, 2019
Ampd Technologies is seeking to make a debut on the public markets soon and purports to have a high performance computing solution that will solve cloud computing's latency issues and the one-size-fits-all philosophy of sector giant, Amazon Web Services (AMZN).
Equity.Guru's own Chris Parry spoke with Anthony Brown, CEO of Ampd, to get a closer look at the company, the potential of its offering and what investors can expect over the next 12 months.
Listen in!
Full disclosure: Ampd Technologies is an Equity.Guru marketing client.
Monday Jul 29, 2019
Monday Jul 29, 2019
Fake NewsTM. You've heard about it, we've written about it. But while it's one thing to read about the Clinton Crime Family and their bodycount, it's another thing entirely to try and make a clear-headed and rational financial investment with so much noise in financial media.
Sometimes it's warranted–here's looking at you Namaste (N.V)–and sometimes it isn't like in the case of Khiron Life Sciences (KHRN.V). Check out their EG tear sheet.
So how to tell the difference? Which outlets tell the truth? And which ones get it right? We don't have all the answers, but we know a good story when we see one and Equity.Guru's own Ethan Reyes is here to tell it.
Listen in!
Full disclosure: Khiron Life Sciences is an Equity.Guru marketing client.
Friday Jul 26, 2019
Friday Jul 26, 2019
While the hype around Libra and Bitcoin's latest run is drawing everyone's attention, there are real no-bullshit blockchain companies making big strides towards mainstream acceptability.
Blockchain Foundry is a small company fulfilling big promises as they realize new vistas in what is still a very misunderstood industry.
Equity.Guru’s own Joseph Morton sat with Blockchain Foundry chief technology officer, Jag Sidhu, to get a better look at the company, the sector and what investors can expect over the next 12 months.
Listen in!
Read more: Deciphering Cryptocurrency: the opportunity in cryptocurrency and blockchain
Full Disclosure: Blockchain Foundry (BCFN.C) is an equity.guru marketing client.
Thursday Jul 25, 2019
Thursday Jul 25, 2019
The power of pot and everything stoner were thought to be keys behind behind the eventual success of legalized cannabis, but as the market matured, health and wellness became the focus. People want more than just getting high, they want to get better.
Companies like 1933 Industries (TGIF.C) saw the writing on the wall and have expanded their THC roster with hemp to service the USD$4.2 trillion global health and wellness market.
Equity.Guru's own Chris Parry sat with 1933 president, Chris Rebentisch, to get a better look at the company, its holdings, the sector and what investors can expect over the next 12 months.
Listen in!
Full disclosure: 1933 Industries is an Equity.Guru marketing client.
Thursday Jul 25, 2019
Thursday Jul 25, 2019
Magnesium is little understood, but an integral part in the manufacture of batteries to automobile frames. Mag One Products (MDD.C) has a unique approach to magnesium production that could see it become one of the world's largest magnesium producers.
Equity.Guru's own Ethan Reyes spoke with Mag One CEO, Gillian Holcroft, to get a look at the company, its groundbreaking value proposition and the magnesium market in general.
Listen in!
Music from https://filmmusic.io
"The Show Must Be Go" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)
Tuesday Jul 16, 2019
Tuesday Jul 16, 2019
Supreme Cannabis (FIRE.T) has quietly gone about forming an empire with strategic acquisitions and partnerships. One of these relationships is with Blissco, a Canadian wellness cannabis brand based in British Columbia.
Equity.Guru's own Ethan Reyes spoke with Blissco founder, Damian Kettlewell, to get a better look at the company, its offering and how it fits within the Supreme model.
Listen in!
Full disclosure: Supreme Cannabis is an Equity.Guru marketing client.
Friday Jul 12, 2019
Friday Jul 12, 2019
Miners and mining have got a bad rap recently. The Imperial Mines tailing pond fiasco showed just how stupid things can get, but mineral exploration plays an important role in our day-to-day lives that cannot be replaced and the Vancouver Island gold rush literally helped put this province on the map.
Equity.Guru's own Gaalen Engen serves a slice of 19th century life to illustrate the timeless importance of mining.
Listen in!
Friday Jul 12, 2019
Friday Jul 12, 2019
More hacks this week are troubling crypto exchanges and Facebook's Libra is turning heads, including the 45th when he isn't glued to Fox and Friends.
Equity.Guru's own Joseph Morton examines the events that shaped up crypto this week.
Listen in!
Read more:
Deciphering Cryptocurrency: Where in the world is Satoshi Nakamoto?
Thursday Jul 11, 2019
Thursday Jul 11, 2019
Someone in the world develops dementia every 3 seconds.
Alzheimer's disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable.
Equity.Guru's own Ethan Reyes takes a quick look at the company and the challenges of the sector. Will biotech provide a safe option to investors while the cannabis market continues to correct?
Listen in!